Literature DB >> 388530

Prostaglandin synthesis by fetal rat bone in vitro: evidence for a role of prostacyclin.

L G Raisz, J Y Vanderhoek, H A Simmons, B E Kream, K C Nicolaou.   

Abstract

Prostaglandin synthesis by fetal rat bones was examined by thin-layer chromatography of culture media after preincubation with labeled arachidonic acid. Cultures in rabbit complement (non-heat inactivated serum) were compared with cultures in heat-inactivated serum or cultures treated with indomethacin. The major complement-dependent products were PGE2, PGF2 alpha and 6-keto-PGF1 alpha, the metabolite of prostacyclin (PGI2). Since PGI2 had not been previously identified in bone its ability to stimulate bone resorption was tested. Repeated addition of PGI2 stimulated release of previously incorporated 45Ca from fetal rat long bones in both short-term and long-term cultures at concentrations of 10(-5) to 10(-9)M. Because of the short half life of PGI2 in solution at neutral pH, we tested a sulfur analog, thiaprostacyclin (S-PGI2) which was found to be a stimulator of bone resorption at concentrations of 10(-5) to 10(-6)M. These studies suggest that endogenous PGI2 production may play a role in bone metabolism. Since vessels produce PGI2 it is possible that PGI2 release may be responsible for the frequent association between vascular invasion and resorption of bone or calcified cartilage in physiologic remodeling and pathologic osteolysis.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 388530     DOI: 10.1016/0090-6980(79)90061-3

Source DB:  PubMed          Journal:  Prostaglandins        ISSN: 0090-6980


  20 in total

1.  Enhanced prostacyclin formation and Wnt signaling in sclerostin deficient osteocytes and bone.

Authors:  Zachary C Ryan; Theodore A Craig; Jeffrey L Salisbury; Lomeli R Carpio; Meghan McGee-Lawrence; Jennifer J Westendorf; Rajiv Kumar
Journal:  Biochem Biophys Res Commun       Date:  2014-04-26       Impact factor: 3.575

2.  Effects of prostacyclin and prostaglandin E1 (PGE1) on bone resorption in the presence and absence of parathyroid hormone.

Authors:  H H Conaway; L F Diez; L G Raisz
Journal:  Calcif Tissue Int       Date:  1986-03       Impact factor: 4.333

3.  Prostaglandins in pathological bone resorption.

Authors:  W Harvey; S Meghji
Journal:  Agents Actions       Date:  1986-10

4.  Bone loss and bone blood flow in paraplegic rats treated with calcitonin, diphosphonate, and indomethacin.

Authors:  A Schoutens; M Verhas; N Dourov; P Bergmann; F Caulin; A Verschaeren; M Mone; A Heilporn
Journal:  Calcif Tissue Int       Date:  1988-02       Impact factor: 4.333

5.  Inflammatory mediators released by complement-derived peptides.

Authors:  H Bult; A G Herman
Journal:  Agents Actions       Date:  1983-08

6.  Demonstration and preliminary characterization of bone resorbing activity in freeze-dried gingiva of dogs.

Authors:  R M Hopps; K Nuki; L G Raisz
Journal:  Calcif Tissue Int       Date:  1980       Impact factor: 4.333

7.  Activation of serum complement inhibits collagen synthesis in fetal rat bone in organ culture.

Authors:  B E Kream; L G Raisz; A L Sandberg
Journal:  Calcif Tissue Int       Date:  1982-07       Impact factor: 4.333

8.  6-Keto-prostaglandin E1-stimulated bone resorption in organ culture.

Authors:  F E Dewhirst
Journal:  Calcif Tissue Int       Date:  1984-07       Impact factor: 4.333

9.  Staphylococcus aureus induces expression of receptor activator of NF-kappaB ligand and prostaglandin E2 in infected murine osteoblasts.

Authors:  Shankari N Somayaji; Samantha Ritchie; Mahnaz Sahraei; Ian Marriott; Michael C Hudson
Journal:  Infect Immun       Date:  2008-09-02       Impact factor: 3.441

10.  The effect of prostaglandins I2, E1, E2 and dibutyryl cyclic AMP on the cytoplasmic spreading of rat osteoclasts.

Authors:  T J Chambers; K Fuller; N A Athanasou
Journal:  Br J Exp Pathol       Date:  1984-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.